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Abstract 
Background 
Older adults prefer comfort over life-sustaining care. Decreased intensity of care is associated with 
improved quality of life at the end-of-life (EOL). 
Objectives 
This study explored the association between advance directives (ADs) and intensity of care in the acute 
care setting at the EOL for older adults. 
Methods 
A retrospective, correlational study of older adult decedents (N = 496) was conducted at an academic 
medical center. Regression analyses explored the association between ADs and intensity of care. 
Results 
Advance directives were not independently predictive of aggressive care but were independently 
associated with referrals to palliative care and hospice; however, effect sizes were small, and the 
timing of referrals was late. 
Conclusion 
The ineffectiveness of ADs to reduce aggressive care or promote timely referrals to palliative and 
hospice services, emphasizes persistent inadequacies related to EOL care. Research is needed to 
understand if this failure is provider-driven or a flaw in the documents themselves. 
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Abbreviation 
ACP Advanced care planning 
AD Advance directives 
CCI Charlson comorbidity index 
HER Electronic health record 
EOL End-of-life 
LOS Length of stay 
LW Living will 
POA-HC Power of attorney for healthcare 
PC Palliative care 
QOL Quality of life 
SDM Surrogate decision-maker 
 
The rapid growth of the aging population1 places increased demands on an already strained healthcare 
system. Given the significant healthcare expenditures in the final year of life,2 the costs of providing 
ongoing care for patients who live longer with chronic, progressive disease will only rise. While 
advanced care planning (ACP) is effective in reducing unnecessary and unwanted care at the end-of-life 
(EOL),3., 4., 5., 6. there is a lack of consistent similar evidence for advance directives (AD). 
Advanced care planning is a process whereby patients receive personalized education about their 
health conditions and are engaged in discussions of EOL preferences,7 while ADs are formal documents 
expressing personal preferences and a designated surrogate decision-maker (SDM).5 Advanced care 
planning is consistently associated with reduced aggressive care,3., 4., 6. increased hospice 
utilization,4., 6. and improved QOL at the EOL.6 However, there is no consistent association between the 
presence of ADs and type of care received, and much of the research on the impact of ADs narrowly 
focus on oncology,4., 6., 8., 9. heart failure,10 or critically ill patients9,11., 12., 13. making it unclear if findings 
generalize to other populations. Additionally, most AD and ACP research includes all adults, neglecting 
the unique needs of the vulnerable older adult population. Many studies rely on SDMs for information 
on the presence or absence of an AD prior to death.5,14., 15., 16. While proxy studies often report an 
association between ADs and limited aggressive care at the EOL, studies in which an AD is confirmed 
within the electronic health record (EHR) do not consistently find this association.9., 11., 12., 17. 
Older adults prefer comfort over treatments that prolong life18., 19.; however, 30% of Medicare 
expenditures are incurred in the final year of life,20 with half resulting from acute 
hospitalizations.21 This inconsistency between patient preferences and delivery of high-technology, 
high-cost care suggests that care delivered near death may not promote quality of life (QOL) at the 
EOL. ACP and ADs have been proposed as means to improve congruence of care with patients' 
preferences. 
The landmark SUPPORT study identified inadequacies of AD documentation22., 23. that persist 
today.19 Inadequate documentation of ADs, both through low rates of completion and poor 
articulation of actual preferences, remains a persistent challenge for EOL care delivery8., 12., 19. Since the 
impact of ADs on the intensity of care delivered to hospitalized older adults at the EOL is not clearly 
established, further objective investigation of the influence ADs exert on care delivery is necessary 
before devoting additional resources toward increasing completion rates of these documents. The 
purpose of this study was to evaluate the relationship between the presence of a documented AD 
within the EHR and the intensity of care received by older adults in the acute care setting at the EOL. 
Theoretical framework 
This study was guided by the Quality Health Outcomes Model (QHOM),24., 25., 26. which posits that 
patient outcomes are influenced by patient characteristics, system characteristics, and interventions. 
The model considers the impact of interventions directly on patient outcomes and integrates both 
patient state and trait characteristics. Fig. 1 illustrates the concepts of the QHOM with the associated 
variables examined in this study. 
 




A retrospective, correlational study was conducted to explore the relationship between ADs and 
intensity of care at the EOL using the EHRs of older adult decedents from a large, tertiary access, level 
one trauma center in the Midwest United States. The sample included patients aged 65 and older, who 
died during a hospital admission between January 2014 and December 2016. Patients were excluded if 
they were discharged to the inpatient hospice service where care was managed within the same 
hospital building by an outside hospice agency. 
Sample 
An a priori G-power analysis27 conducted for a medium effect28 indicated that a total sample of 485 
people was necessary to detect a moderate effect with 80% power. An institutional self-service cohort 
discovery tool (i.e. an electronic data warehouse) was used to identify potential patients guided by the 
following inclusion criteria: age ≥ 65, deceased, inpatients, and admission to the same hospital. Date of 
death was matched with the date of discharge to verify that death occurred during the terminal 
admission. All subjects that did not die during hospital admission were excluded. 
Study variables 
Predictor variable 
The presence or absence of an AD signed before the terminal hospital admission, either present in the 
medical record prior to admission or added to the EHR within 24 h of admission, and retrievable from 
the EHR, served as the binary predictor variable (e.g., yes/no). An AD signed after hospital admission 
was coded as no. 
Outcome variables 
Variables for intensity of care were selected following an extensive literature review with the most 
common variables included in this study.4., 5., 6.,9., 10., 11., 12.,14., 16., 17. Outcome variables were categorized 
into indicators of either aggressive or conservative care. Aggressive care measures were mechanical 
ventilation (MV), new initiation of artificial enteral nutrition, admission or transfer to the intensive care 
unit (ICU) and ICU length of stay, cardiopulmonary resuscitation (CPR), new dialysis including 
hemodialysis and continuous renal replacement therapy (CRRT), invasive procedures such as 
bronchoscopy, surgical procedures or tube placement (e.g., chest tube, external ventricular drain, 
permanent feeding tube), and the use of cardiovascular supports (e.g., vasopressors, intra-aortic 
balloon pump, extracorporeal membranous oxygenation, or new placement of a ventricular access 
device). Measures of conservative care were palliative care (PC) consultation, hospice referral, a do-
not-resuscitate code status at death, and utilization of comfort care order sets. Palliative and hospice 
referrals were considered present if a consult note was present in the EHR. Date of consultation was 
noted with respect to the number of days consultation occurred prior to death. 
Confounding variables 
With existing literature focused on specific diagnoses, this study specifically included multiple 
comorbidities and stratified based on overall disease burden. Data were collected for age, sex, race, 
ethnicity, and preexisting comorbidities guided by the QHOM framework. The Charlson Comorbidity 
Index (CCI)29., 30. was used to measure comorbid conditions. The CCI has been validated in acute care 
populations31., 32., 33., 34. and predicts one-year mortality based on chronic disease and age, with a higher 
CCI score predicting a higher risk of death.31., 32., 33., 34. Its predictive ability has remained consistent 
from International Classification of Diseases, version 9 (ICD-9)35 to ICD-10.36., 37., 38. 
Data collection 
Data were abstracted from the EHR. Every medical record was searched by the author M.T. for each 
variable of interest and logged onto a data collection form, identified only by a unique study identifier. 
Ten percent of data forms were audited by author J.G for accuracy. 
Statistical analysis 
Logistic regression was performed to evaluate the association of predictors with care received in the 
acute care setting at the EOL, α set to < .01. Rejection of the null hypothesis indicated that the model 
was able to differentiate between those who did and did not receive the outcome of interest. All 
analyses were conducted using SPSS, v24.39 Modeling began with all predictor variables (AD, age, CCI, 
and sex). In an intentional, step-down fashion, predictors for subsequent models were individually 
removed, based on the statistical significance of their unique contribution to a given model, and the 
model was re-run with remaining predictors. At each step, models were compared with a Likelihood 
Ratio Test (LRT). A non-significant difference between the two models resulted in retention of the 
more parsimonious model. This process was repeated until the most parsimonious model was 
identified. Outcome variables for which ADs were significantly associated were further analyzed 
utilizing t-tests, equal variances assumed, to evaluate mean differences between those with and 
without an AD. 
Multiple regression was performed to evaluate the impact of predictor variables on the continuous 
outcome variable, total ICU LOS, for the subgroup of patients who received ICU care (n = 426). Utilizing 
a step-down approach, predictors were removed based on the statistical significance of their unique 
contribution to a given model. F ratio tests were used to compare models, and the most parsimonious 
model, without a significant F ratio change, was retained. For both logistic and multiple regression 
analyses, the AD predictor (variable of interest) was never removed from any model, regardless of 
statistical significance. 
Race and ethnicity were excluded as predictors due to an overrepresentation of Caucasians (78.8%) 
and underrepresentation of all other groups in the sample population relative to the local 
demographics of the general population.40 Additionally, 3.6% of subjects were identified as “unknown” 
for race and ethnicity. The standardized residuals of CCI, removing the effect of age, served as the CCI 
variable in all analyses thus eliminating the correlation between age and CCI that was present in 
preliminary analyses. Finally, descriptive analyses indicated that patients who received extracorporeal 
membranous oxygenation, intra-aortic balloon pump, or new placement of a ventricular access device 
therapies were captured within the variable, vasopressors. Analyses of those therapies were 
subsequently excluded. Probabilities for differences in outcomes associated with ADs are reported 
regardless of the statistical significance of the AD predictor in the model to report all associations 
identified between ADs and care delivered. 
Ethical considerations 
This study was approved by all required institutional review boards and compliance offices. 
Results 
Nine hundred fifty-nine patients met inclusion criteria of which 496 cases were selected, using 
computerized randomization, for data collection and analysis. Demographic characteristics, descriptive 
statistics of comorbidities, and outcome variables are presented in Tables 1 and 2. The variance 
explained by each overall model is reported (Fig. 2) using Nagelkerke's pseudo-R2 (RPseudo2). Table 
3, Table 4, Table 5, Table 6 summarize all regression models and model comparisons, including χ2, OR, 
and RPseudo2. 
Table 1. Demographic characteristics 
Characteristic Value 
Subjects, N (%) 496 (100) 
 Women 252 (48.8) 
 Men 254 (51.2) 
Age, M (SD) total 78.52 (8.58) 
 Women 79.59 (8.44) 
 Men 77.51 (8.61) 
Marital status, n 
 
 Married 222 
 Single 69 
 Widowed 139 
 Divorced 37 
 Legally separated 6 
 Significant other 1 
 Unknown 22 
Race, n 
 
 White or caucasian 391 
 Black or African American 67 
 Hispanic 11 
 Asian 7 
 American Indian or Alaska Native 1 
 Other 1 
 Unknown 18 
Ethnicity, n 
 
 Non-hispanic 465 
 Hispanic 11 
 Unknown 20 
Advance directives on file, n (%) 232 (46.8) 
 women 110 (43.7) 
 men 122 (48.0) 
Types of advance directives, n 
 
 POA-HC 181 
 LW 3 
 POA-HC and LW 42 
 State DNR 5 
 SNF form 1 
POA-HC, Power of attorney for healthcare; LW, Living will. 
DNR; Do Not Resuscitate; DNR, Do Not Resuscitate; SNF; Skilled Nursing Facility. 
 
Table 2. Comorbidity burden and outcome variable distributions among participants 
Characteristic Value 
Outcome variables, n (%) 
 
 Dialysis 90 (18.1) 
 Invasive procedures 208 (41.9) 
 Mechanical ventilation 310 (62.5) 
 Artificial enteral nutrition 156 (31.5) 
 Cardiovascular support 252 (50.8) 
 Admission or transfer to ICU 427 (86.1) 
 Comfort care order set 296 (59.7) 
 Cardiopulmonary resuscitation 105 (21.2) 
 Code status at death (DNR) 353 (71.2) 
 Palliative care consultation 143 (28.8) 
 Hospice referral 143 (28.8) 
Comorbidity burden, n (any history of), n 
 
 Acute MI 56 
 Cerebrovascular disease 127 
 Chronic pulmonary disease 137 
 Connective tissue disease 29 
 Dementia 71 
 Heart failure 166 
 Mild liver disease 22 
 Any non-metastatic malignancy 115 
 Diabetes without complications 113 
 Diabetes with complications 38 
 Hemi- or paraplegia 26 
 HIV/AIDS 0 
 Metastatic solid tumor 57 
 Moderate or severe liver disease 8 
 Renal disease 153 
 Peptic ulcer disease 30 
 Peripheral vascular disease 101 
 
 
Fig. 2. Percentage of variance explained by each retained model for each outcome variable. 
 
  
Table 3. Logistic regression models of intensity of care outcome variables 
Outcome Predictors B SE Wald df P OR 95% CI 
Dialysis 
        
 
Advance directive −0.111 0.243 0.208 1 .648 0.895 [0.556, 1.441]  
Age −0.078 0.016 24.532 1 < .001 0.925 [0.896, 0.954]  
(Intercept) −1.596 0.171 87.307 1 < .001 0.203 
 
Invasive procedures 
        
 
Advance directive −0.294 0.189 2.420 1 .120 0.745 [0.514, 1.080]  
Age −0.058 0.011 26.056 1 < .001 0.943 [0.923, 0.965]  
(Intercept) −0.213 0.128 2.770 1 .096 0.809 
 
Mechanical ventilation 
        
 
Advance directive −0.477 0.200 5.704 1 .017 0.620 [0.419, 0.918]  
Age −0.070 0.012 34.610 1 < .001 0.932 [0.911, 0.954]  
CCI −0.268 0.100 7.119 1 .008 0.765 [0.628, 0.931]  
(Intercept) 0.795 0.140 32.157 1 < .001 2.214 
 
Artificial nutrition 
        
 
Advance directive 0.028 0.197 0.020 1 .889 1.028 [0.699, 1.512]  
Age −0.036 0.012 9.648 1 .002 0.964 [0.942, 0.987]  
(Intercept) −0.810 0.135 35.994 1 < .001 0.445 
 
Cardiovascular support 
        
 
Advance directive −0.288 0.189 2.311 1 .128 0.750 [0.517, 1.087]  
Age −0.072 0.011 39.373 1 < .001 0.930 [0.910, 0.952]  
(Intercept) 0.166 0.129 1.645 1 .200 1.180 
 
Admission or transfer to ICU 
        
 
Advance directive −0.436 0.267 2.673 1 .102 0.647 [0.383, 1.091]  
Age −0.051 0.016 10.820 1 .001 0.950 [0.922, 0.980]  
(Intercept) 2.119 0.201 111.361 1 < .001 8.326 
 
Comfort care orderset use 
        
 
Advance directive 0.323 0.184 3.061 1 .080 1.381 [0.962, 1.983]  
(Intercept) 0.244 0.124 3.860 1 .049 1.276 
 
Received CPR 
        
 
Advance directive −0.544 0.231 5.559 1 .018 0.581 [0.370, 0.912]  
Age −0.042 0.014 9.161 1 .002 0.959 [0.934, 0.985]  
(Intercept) −1.123 0.146 59.540 1 < .001 0.325 
 
Code status at death 
        
 
Advance directive −0.692 0.309 5.001 1 .025 0.501 [0.273, 0.918]  
(Intercept) −1.846 0.179 105.929 1 < .001 0.158 
 
Palliative care consult 
        
 
Advance directive 0.558 0.200 7.783 1 .005 1.748 [1.181, 2.587]  
(Intercept) −1.181 0.145 66.182 1 < .001 0.307 
 
Hospice referral 
        
 
Advance directive 0.679 0.201 11.389 1 .001 1.972 [1.329, 2.925]  




Table 4. Multiple regression model for total ICU length of stay outcome variable 
 
Predictors b SE b β t p 95% CI 
Total ICU 
LOS 
(Intercept) 4.802 0.426 
 
11.283 < .001 [3.965, 5.638] 
 
Advance directive 0.114 0.626 0.009 0.182 .856 [−1.116, 1.344]  
Age −0.148 0.036 −0.195 −4.078 < .001 [−0.220, 
−0.077] 
ICU, Intensive Care Unit; LOS, Length of Stay. 
Table 5. Logistic regression likelihood ratio test 
Model χ2 (df) pmodel Δχ2 (Δdf) pdifference 
Dialysis 
    
1 (all predictors) 35.206 (4) < .001 
  
2 (removed sex) 35.047 (3) < .001 0.159 (1) .6901 
3⁎⁎⁎ (removed sex + CCI) 28.855 (2) < .001 6.192 (1) .0128 
4 (removed sex + CCI + age) 0.919 (1) .338 27.936 (1) < .00001 
Invasive procedures 
    
1 (all predictors) 34.939 (4) < .001 
  
2 (removed sex) 34.897 (3) < .001 0.042 (1) .8376 
3⁎⁎⁎ (removed sex + CCI) 31.912 (2) < .001 2.985 (1) .0840 
4 (removed sex + CCI + age) 4.252 (1) .039 27.66 (1) < .00001 
Mechanical ventilation 
    
1 (all predictors) 56.155 (4) < .001 
  
2⁎⁎⁎ (removed sex) 55.634 (3) < .001 0.521 (1) .4704 
3 (removed sex + CCI) 48.453 (2) < .001 7.181 (1) .0074 
4 (removed sex + CCI + age) 12.496 (1) < .001 43.138 (2) < .00001 
Artificial nutrition 
    
1 (all predictors) 10.609 (4) .031 
  
2 (removed sex) 10.609 (3) .014 0 (1) 1 
3⁎⁎⁎ (removed sex + CCI) 9.979 (2) .007 0.63 (1) .4274 
4 (removed sex + CCI + age) 0.035 (1) .851 9.944 (1) .0016 
CV support 
    
1 (all predictors) 48.470 (4) < .001 
  
2 (removed sex) 48.191 (3) < .001 0.279 (1) .5974 
3⁎⁎⁎ (removed sex + CCI) 47.315 (2) < .001 0.876 (1) .3493 
4 (removed sex + CCI + age) 4.573 (1) .032 42.742 (1) < .00001 
Admit/Transfer to the ICU 
    
1 (all predictors) 18.645 (4) .001 
  
2 (removed sex) 18.359 (3) < .001 0.286 (1) .5928 
3⁎⁎⁎ (removed sex + CCI) 15.197 (2) .001 3.162 (1) .0754 
4 (removed sex + CCI + age) 4.033 (1) .045 11.164 (1) .0008 
Comfort care orderset 
    
1 (all predictors) 5.182 (4) .269 
  
2 (removed age) 5.134 (3) .162 0.048 (1) .8266 
3 (removed age + sex) 4.784 (2) .091 0.35 (1) .5541 
4⁎⁎⁎ (removed age + sex + CCI) 3.076 (1) .079 1.708 (1) .1912 
Received CPR 
    
1 (all predictors) 17.472 (4) .002 
  
2 (removed CCI) 17.470 (3) .001 0.002 (1) .9643 
3⁎⁎⁎ (removed CCI + sex) 16.792 (2) < .001 0.678 (1) .4103 
4 (removed CCI + sex + age) 7.227 (1) .007 9.565 (1) .0020 
Code status at time of death 
    
1 (all predictors) 9.484 (4) .050 
  
2 (removed sex) 9.455 (3) .024 0.029 (1) .8648 
3 (removed sex + CCI) 8.936 (2) .011 0.519 (1) .4713 
4⁎⁎⁎ (removed sex + CCI + age) 5.281 (1) .022 3.655 (1) .0559 
Received PC consult 
    
1 (all predictors) 11.386 (4) .023 
  
2 (removed age) 11.381 (3) .010 0.005 (1) .9436 
3 (removed age + sex) 11.162 (2) .004 0.219 (1) .6398 
4⁎⁎⁎ (removed age + sex + CCI) 7.860 (1) .005 3.302 (1) .0692 
Received hospice consult 
    
1 (all predictors) 13.039 (4) .011 
  
2 (removed sex) 13.020 (3) .005 0.019 (1) .8904 
3 (removed sex + CCI) 13.002 (2) .002 0.018 (1) .8933 
4⁎⁎⁎ (removed sex + CCI + age) 11.572 (1) .001 1.43 (1) .2318 
χ2, chi square; df, degrees of freedom; pmodel, significance of the individual model; Δχ2, change in chi square 
between models; Δdf, change in degrees of freedom between models; pdifference, significance of the Δχ2. 
⁎⁎⁎ retained model. 
 
Table 6. Multiple regression model summary 
Model 
summarye 
          
Model R R2 Adjusted R2 SE Change 
statistics 
    Durbin–
Watson      
ΔR2 ΔF df1 df2 p 
 
1 .199a 0.040 0.031 6.417 0.040 4.369 4 422 .002 
 
2 .199b 0.040 0.033 6.411 0.000 0.096 1 422 .757 
 
3⁎⁎⁎ .195c 0.038 0.033 6.408 −0.002 0.724 1 423 .395 
 
4 .013d 0.000 −0.002 6.525 −0.038 16.627 1 424 < 
.001 
2.058 
a Predictors: Sex, CCI, Age, Advance Directive. 
b Predictors: CCI, Age, Advance Directive. 
c Predictors: Age, Advance Directive. 
d Predictors: Advance Directive. 
Dependent Variable: Total ICU Length of Stay. 
⁎⁎⁎ retained model. 
 
Advance directives 
Two hundred and thirty-two decedents (46.8%) had some form of AD present within their medical 
record within the first 24 h of admission (Table 1). Various types of ADs were identified. The 
overwhelming majority of ADs were power of attorney for healthcare (POA-HC) documents, n = 181, as 
compared to living wills (LW), n = 3. An additional n = 42 individuals had both a POA-HC and a LW. POA-
HC and LW documents were State of Wisconsin templates. Those with both a POA-HC and a LW had 
either formal state templates, the Five Wishes document, or a standardized form for Jehovah's 
Witnesses. 
Indicators of aggressive care 
Advance directives were not associated with receiving new dialysis, undergoing invasive procedures, 
receiving MV, artificial nutrition, CV supports, ICU care, ICU length of stay, or receiving CPR. Models 
containing AD and age were able to differentiate between those who did and did not receive new 
dialysis (p < .001), invasive procedures (p < .001), artificial nutrition (p = .007), CV supports (p < .001), 
ICU care (p = .001), or CPR (p < .001), where only age made a significant contribution to each model 
(Table 3). For each one year older, the likelihood of receiving new dialysis, undergoing invasive 
procedures, receiving artificial nutrition, CV supports, ICU care, or CPR decreased by 7.5%, 5.7%, 3.6%, 
7%, 5%, and 4.1%, respectively. The model containing AD, age, and CCI was able to differentiate 
between those who did and did not receive MV (p < .001), where both age (p < .001) and CCI (p < .001) 
made significant contributions. With all other variables held constant, both age and comorbidity 
burden decreased the likelihood of receiving MV, 6.8% and 23.5%, respectively. For the subgroup of 
individuals who received ICU care (n = 426), the predictors age and AD contributed to the most 
parsimonious model for ICU LOS (p < .001); however, only age made a significant contribution 
(p < .001). Total ICU LOS was 0.11 days longer for those patients with an AD (p = .856). Older patients 
had shorter lengths of stay—each year older was associated with a decreased LOS by 0.15 days 
(p < .001). 
Indicators of conservative care 
No predictors made meaningful contributions to modeling for either comfort care order sets (p = .79) 
or code status (p  = .22) (Table 3). While patients with ADs were half as likely to be a full code, this was 
not statistically significant (p = .025). 
Advance directives were associated with referrals to both PC (p = .005) and hospice (p = .001). An AD 
was associated with an increased likelihood of referral (74.8% and 97.2%, respectively). Additional 
analyses were performed to describe the mean difference in the number of days before death of PC 
and hospice referrals by AD presence. There was no mean difference between the presence 
(n = 80, M = 4.39, s = 5.328) or absence (n = 62, M = 3.79, s = 6.135) of an AD and the number of days 
prior to death that palliative care was consulted (p = .536). Similarly, there was no mean difference 
between the presence (n = 85, M = 3.32, s = 3.364) or absence (n = 59, M = 3.46, s = 6.516) of an AD 
and the number of days prior to death of hospice referral (p = .866). 
Discussion 
The purpose of this study was to evaluate the relationship between the presence of ADs in the EHR and 
the intensity of care received by older adults in the acute care setting at the EOL. Indicators of both 
aggressive and conservative care were studied. Advance directives were not independently associated 
with receipt of aggressive care at EOL; however, ADs were associated with increased referrals to 
palliative care and hospice. Despite increased referrals, ADs were not associated with early initiation of 
these services. 
Echoing other studies,9., 17., 41. any effect ADs exerted toward aggressive treatment was influenced by 
age, and in the case of MV, by comorbidity burden. This is not, per se, an indication that ADs are 
ineffective. While an AD was not an independent predictor in any model, when holding other predictor 
variables constant, individuals with an AD were less likely to receive ICU care, new dialysis, invasive 
procedures, MV, CV supports, and CPR. This suggests that ADs have a role in reducing aggressive care, 
but that more can be done to optimize these benefits to make a meaningful impact on EOL care. 
Preferences may not be documented in ADs with enough detail to guide care at the EOL. Legislation 
through the Patient Self Determination Act has focused on increasing AD documentation via mandates 
to acute care facilities.42 However, if care decisions are more impacted by patient factors than by ADs, 
perhaps efforts should focus on increasing ACP interventions in conjunction with AD completion as ACP 
communication has been found to decrease aggressive care4., 5. in a way that promotes QOL at the 
EOL.6 Linking ACP conversations with AD completion may be necessary to improve the effectiveness of 
ADs to promote congruent care and decrease potentially unwanted aggressive care. 
The unique influence of ADs was only present for PC consults and hospice referrals; however, the 
effect sizes were small, potentially related to the smaller number of patients who received these 
referrals (n = 143). While the benefit of these services has been previously described,43 the current 
study emphasizes that simply demonstrating an increased number of consultations and referrals is not 
enough. Aggressive care was not significantly reduced in the sample overall, and referrals to both PC 
and hospice were late, regardless of AD status. The benefits of early palliative and hospice 
referrals44., 45. are overlooked by providers, who may perceive the initiation of these services as 
failure.46., 47. Palliative care is an underutilized service that, when integrated within the acute care 
setting, reduces costs and more importantly, improves the dying process.48., 49. Additionally, hospice 
referral more than three days before death is associated with higher quality of death.18., 50. Changing 
the culture within healthcare that tends to avoid these services is a major undertaking but a necessary 
step toward improving EOL care.19 
No model explained more than 14.5% of the variance in any outcome variable, and half of the models 
explained 5% or less. Retrospective studies, by their nature, are incapable of capturing the context in 
which EOL decision-making occurs in addition to other influences, such as severity of illness, 
socioeconomic factors, cultural values and beliefs, support systems, and SDM selection. In situations 
where SDMs must make difficult decisions, known patient preferences and values can often be at odds 
with SDMs’ own needs and desires to avoid perceived responsibility for a loved one's death.51 The 
inability of surrogates to separate their own interests from those of patients may play a role in 
decisions made at the EOL, which suggests while documentation of patient preferences is important, 
communication of those preferences to SDMs and loved ones is essential. These scenarios further 
emphasize the need of support from PC teams and medical recommendations of providers in 
navigating goals of care discussions. Future prospective studies are needed to capture these contextual 
factors. 
The proportion of patients in the current study with an AD (46.8%) is consistent with previous studies 
utilizing objective data from the EHR as opposed to a proxy report of AD presence.8., 10. Studies that 
obtain data from SDMs tend to be more optimistic regarding the effectiveness of ADs to both minimize 
aggressive care and promote care that is congruent with patient preferences.5., 15., 16. Poor awareness of 
these differences may encourage a false sense of security in documents that may not be effective in 
their current form. The failure to improve rates of AD completion over time provides further support 
for the need to reassess not only provider encouragement to complete such documents, but overall 
provider engagement in ACP to optimize patient QOL at the EOL. 
Finally, it is important to note that of those patients who completed a single AD document, the 
overwhelming majority completed only a POA-HC. Of all decedents, fewer than 1 in 5 completed both 
a POA-HC and LW. Since a POA-HC is the document that identifies a designated SDM, it is plausible that 
the failure of ADs in this study to have an impact on aggressive care or timely referrals to PC and 
hospice was, in part, due to a focus on simply identifying a trusted SDM. While patients trust a 
designated SDM's ability to exercise substituted judgment, designees may not believe they truly know 
their loved one's preferences.52 In fact, even for patients with both a LW and POA-HC document, the 
designated SDM can override the LW document. This discordance lends support for the role of primary 
care and specialty providers in promoting ACP discussions that integrate both patients and their 
designated SDMs as well as encouraging AD documentation that provides a window into patients’ 
values and preferences to guide future decision-making. Additionally, providers delivering care to 
hospitalized patients in the acute care setting should be aware of this potential inconsistency early and 
focus efforts on identifying patient values and preferences to prepare surrogates for their potential 
role in substituted judgment decision-making. 
Implications 
The Centers for Medicare and Medicaid have recognized that financial incentives might motivate 
providers to more actively engage their patients in EOL discussions.43 With the recent changes from the 
Centers for Medicare and Medicaid, providers should consider an increased focus on ACP with 
patients. The current healthcare climate is increasingly focused on translational science, 
interprofessional education and collaboration to improve patient care. All healthcare providers, 
especially physicians, nurses, advanced practice providers, and social workers can work collaboratively 
to focus efforts on improving ACP and AD documentation. Future research should use an 
interdisciplinary focus when developing targeted interventional studies toward improving ACP and 
increasing the completion of meaningful ADs that are practical and applicable to bedside providers. 
Studying the impact of new EHR solutions that capture conversations and goals of care discussions in 
addition to AD documents may have relevance. 
In addition to focusing on the process of AD completion, understanding better how providers utilize 
these documents requires further study. Are ADs routinely reviewed by physicians and advanced 
practice providers? Are documents reviewed only when a patient is incapacitated, or are they 
interwoven into the fabric of routine decision-making with decisional patients? Do providers 
encourage family members and SDMs to adhere to documented preferences or are they fearful of 
litigation if they fail to appease SDMs? And what of patient autonomy? Are these documents not the 
patient's autonomous wishes in the event they are not able to express their own preferences? The 
SUPPORT study raised concerns regarding the specificity of AD documents as a barrier to their 
utility.54 Further research should ascertain if this remains the case – Are ADs crafted in a way that 
provides sufficient detail to truly direct care? 
In demonstrating persistently low rates of AD documentation, this study provides additional evidence 
for the need to increase documentation of patient preferences. Lack of documentation leads to 
inadequately communicated preferences between patients and their families and increased decisional 
conflict.53 Providers have a responsibility to engage with patients and their families, who want to have 
EOL discussions.54 The trust that patients place in their providers55., 56. creates opportunities for ACP 
conversations. Yet all too often, these do not occur57., 58. and when they do, patient preferences are not 
documented. If, as may have been in this study, the majority of people are simply identifying a 
designated SDM at the exclusion of documenting their values and preferences, efforts must focus on 
educating patients on the importance of detailing information to guide future decisions. Whether 
patients’ ADs request limits in treatment or all interventions possible, providers are influenced by 
written preferences.59 More must be done in medical and nursing schools to prepare providers to 
engage in these difficult conversations with a sense of comfort and confidence.60., 61. 
Limitations 
The exclusion of those who died in hospice may have limited the breadth of data retrieved for 
assessing the influences of ADs on EOL care decisions. This applies, as well, to the exclusion of those 
patients who died outside of the hospital, where extraneous variables that contributed to decision-
making within the acute care setting may not have been captured. 
Despite literature suggesting that older adults prefer comfort over life-sustaining treatment, decedents 
in this study may have preferred aggressive care. Surrogate decision-makers may have had this 
knowledge, which could explain the lack of association between the presence of an AD and decreased 
aggressive care. This study did not address the question of whether patients received the care that 
they preferred, but rather if simply having an AD, as encouraged through federal mandates, had any 
relationship with intensity of care received at the EOL. A prospective study would better ascertain this 
relationship. If more aggressive care is desired, these preferences should be documented within an AD, 
especially given that this study did confirm an association between increasing age and decreased 
aggressive care. 
Patients who signed an AD document after admission were excluded under the assumption that care 
discussions did not occur until after admission. However, discussions, without formal documentation 
of preferences, may have occurred well in advance of hospitalization. Likewise, patients without an AD 
in the EHR were coded as not having an AD. The absence of an AD in the EHR does not in and of itself 
indicate that there is no AD document or that no ACP discussions have occurred. A prospective study 
to elicit the timing of discussions and preferences from patients and families could overcome these 
limitations and should be considered in future studies. 
This study had no access to EHRs that were held by outside organizations. Patients categorized as 
having no AD may have had one filed within another healthcare system, and providers, at the time of 
the patient's care, may have had access to outside records that included an AD. Our retrospective 
study could not track if ADs were accessed in this manner. 
Finally, as a large, urban, tertiary medical center, it was anticipated that the population would 
represent the larger urban community; however, the racial composition of this convenience sample 
was not found to be representative of the surrounding area.40 Caucasian patients were 
overrepresented with minority underrepresentation most significant among Hispanic patients; 
therefore, no conclusions could be drawn related to the influence of race and ethnicity relative to ADs 
and intensity of care received. 
Conclusion 
Our healthcare and legal systems have placed a high value on creating a formal AD; however, this value 
may be misplaced. This study's findings mirror others who have failed to consistently confirm the 
effectiveness of ADs to reduce aggressive care. The time has come for the focus to shift from 
document completion for the sake of fulfilling a legislative mandate to increasing efforts to build 
systems that promote meaningful and timely discussion of treatment preferences through robust ACP 
processes. Efforts to improve the quality of EOL care must begin with the acknowledgment that the 
current system is ineffective to achieve our stated goals to open the door for multidisciplinary 
discussions aimed to improve QOL at the EOL. 
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